Abrogation of lymphocyte trapping by ascitic tumours.
D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D000942:Antigens, Bacterial; D002465:Cell Movement; D002860:Chromium Radioisotopes; D004912:Erythrocytes / Q000276:immunology; D006433:Hemocyanins; D007111:Immunity, Cellular; D007114:Immunization; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008099:Liver / Q000276:immunology; D008198:Lymph Nodes / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008974:Mollusca / Q000276:immunology; D009368:Neoplasm Transplantation; D012475:Salmonella / Q000276:immunology; D012513:Sarcoma, Experimental / Q000276:immunology*; D012756:Sheep / Q000276:immunology; D013154:Spleen / Q000276:immunology*
D000941:Antigens; D000942:Antigens, Bacterial; D002860:Chromium Radioisotopes; D006433:Hemocyanins